26Sep
25Sep
BrandVerge and gimmefy.ai Forge Strategic Partnership
BrandVerge, a premier advertising agency renowned for its data-driven and audience-centric campaigns, today announced a groundbreaking partnership with gimmefy.ai, the world's first customised AI marketing platform. This collaboration aims to redefine the landscape of media planning & buying by seamlessly integrating advanced AI capabilities into BrandVerge's comprehensive suite of services including all aspects of paid media strategy and activation. The partnership between BrandVerge and gimmefy.ai represents a significant leap forward in the advertising industry, combining human expertise with cutting-edge artificial...
24Sep
Wasabi Technologies Powers Johnson Controls with Unmatched Cloud Storage for Mission Critical Video Management
Wasabi Technologies, the hot cloud storage company, today announced it is partnering with Johnson Controls, which offers the world's largest portfolio of building technology, software and services, to deliver high-performance, secure, and cost-effective cloud storage for the video surveillance industry. The combination of Wasabi hot cloud storage and Johnson Controls’ exacqVision Video Management System (VMS) brings organizations an affordable, fully integrated cloud storage and VMS solution with the added security of Wasabi’s immutable buckets to help prevent data loss. "Wasabi...
24Sep
Immusoft to Announce Positive Phase 1 Data for First Engineered B Cell Therapy in a Clinical Trial
Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation (""Immusoft""), a cell therapy company dedicated to improving the lives of patients with rare diseases, today announced positive results from the Phase 1 ISP-001 trial evaluating the therapy in a patient with mucopolysaccharidosis type I (MPS I). The clinical trial is supported by an $8 million award from the California Institute for Regenerative Medicine (CIRM), one of the world's largest institutes dedicated to regenerative medicine. ""Although the Phase 1 focus...
21Sep
University of Arizona Professor Recognized for VR Sight-Enhancing Tech
A longtime University of Arizona optics professor has been honored along with other scientists who used federal funding to invent life-changing technology — in Hong Hua’s case, helping the nearly blind to see clearly. Hua, director of the UA’s 3D Visualization and Imaging Systems laboratory, was featured in the Bayh-Dole Coalition’s 2024 “Faces of American Innovation” report for her invention of an optical device that uses virtual- and augmented-reality technology to allow those with significant vision loss to see with...
19Sep
Game-Changing Neuroprotection: Astrocyte Pharmaceuticals Breakthrough in Brain Injury Treatment
"The air is crisp, and the sounds of whistles fill the air. The excitement is tangible as football, soccer, and other fall sports go into full swing. Yet behind the scenes of every game is the harsh reality of what happens when an athlete takes a hit—a momentary blackout, disorientation, and the fear of lasting damage. For too long, the best available treatments for concussions and brain injuries have been limited to rest and observation. Astrocyte Pharma, however,...
18Sep
EarthGrid Announces Groundbreaking Joint Venture with EnerTech, a KIA Entity, to Deploy $18B in U.S. Underground Utility Projects
EarthGrid, a Bay-area plasma tunnel-boring technology and infrastructure development company, announced today that it has signed a joint venture agreement with EnerTech, a Kuwait Investment Authority (KIA) entity, to deploy infrastructure projects in four phases across the United States, Europe and the Middle East. The first two phases consist of, in estimate, $18 billion in U.S. infrastructure improvement projects. Utilizing EarthGrid’s patented plasma-powered machines, this joint venture will develop a network of underground tunnels designed to upgrade the current power...
17Sep
RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients
RevBio, Inc., announced that it has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disease and Stroke (NINDS), part of the National Institutes of Health (NIH). This two-year grant (1R44NS135736-01A1) will allow the company to complete a 20-patient pilot clinical trial to examine the safety and efficacy of the company’s bone adhesive biomaterial called TETRANITE® which will be used to immediately fixate cranial flaps and enable bone fusion following...
17Sep
Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease
Xylyx Bio, Inc., a regenerative medicine company developing pioneering solutions for tissue and organ modeling and repair, announced today that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for liver fibrosis. Fibrosis is a prevalent disease process...
13Sep